Urticaria clinical trials
The registry lists 147 studies for Urticaria across more than 10 countries. 19 are recruiting or about to start. 64 of them are mainly about Urticaria (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-02. Counting its 4 narrower conditions too, such as Chronic Urticaria: 531 studies, 92 open.
Get an email when these change. Save the Urticaria studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Who runs them
Organon and Co (9) · Charite University, Berlin, Germany (8) · Novartis Pharmaceuticals (7) · JDP Therapeutics, Inc. (4) · Genentech, Inc. (4) · University of Mississippi Medical Center (3) · AO GENERIUM (3) · University of Nebraska (3)
What is being tested here
Drugs under test in Urticaria studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted
| Drug | Open | Phase 3 | All |
|---|---|---|---|
| PF-06651600 | 1 | 0 | 1 |
| Desloratadine | 0 | 3 | 10 |
| Omalizumab | 0 | 2 | 7 |
| Bilastine | 0 | 2 | 6 |
| Cetirizine | 0 | 1 | 4 |
| Levocetirizine | 0 | 1 | 4 |
| Ligelizumab | 0 | 1 | 3 |
| Briquilimab | 0 | 0 | 2 |
| Cholecalciferol | 0 | 1 | 2 |
| Dupilumab | 0 | 0 | 2 |
Drug classes tested here Tyrosine kinase inhibitors (TKIs) 1 open · Antihistamines 23
Coming up
Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.
All 5
- Dec 2026A Study to Learn About Ritlecitinib for the Potential Treatment of Chronic Spontaneous Urticaria in Adults. · Pfizer
- Jan 2027Allergy and Immunology Natural History Study · Columbia University
- Mar 2027Comparing Standard-Dose and High-Dose Cetirizine for Acute Urticaria · University of Phayao
- Jul 2027Angioedema Biomarker Research Study · Foundation For Rare Disease Research
- Aug 2027A Phase 1 Study of GTX-B001 in Healthy Subjects and Patients With Chronic Inducible Urticaria · Granular Therapeutics Limited
Who these studies take
Of the 12 Urticaria studies recruiting now, 3 (25%) set no upper age limit and 6 (50%) stop at 75 or younger. 6 (50%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 6 (50%) take healthy volunteers.
| Age | Women | Men |
|---|---|---|
| 10 | 3 (25%) | 3 (25%) |
| 18 | 12 (100%) | 12 (100%) |
| 30 | 11 (92%) | 11 (92%) |
| 40 | 11 (92%) | 11 (92%) |
| 50 | 11 (92%) | 11 (92%) |
| 65 | 9 (75%) | 9 (75%) |
| 75 | 8 (67%) | 8 (67%) |
| 85 | 5 (42%) | 5 (42%) |
Across all 147 studies, recruiting or not: 52% stop at 75 or younger and 33% at 65; 30% take children; 1% are for women only and 2% for men only; 27% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
How long Urticaria studies take
Of 13 phase 2 interventional studies under Urticaria, half reached primary completion within 28 months of starting, counting those still running.
| Start to primary completion | Every sponsor | Industry | Non-industry |
|---|---|---|---|
| Phase 2 | 28 mo15–32 · 13 studies | — | — |
Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out
What changed recently
From the registry's own updates since Oct 12, 2026.
Started recruiting1
Studies
Recruiting first, then most recently updated. Showing 50 of 147. Browse all 147 → or search them.
- A Study to Assess the Efficacy and Safety of THB335 in Adults With Chronic Spontaneous Urticaria (CSU)RecruitingNCT07766499Phase 21 country
- A Phase 1 Study of GTX-B001 in Healthy Subjects and Patients With Chronic Inducible UrticariaRecruitingNCT07181369Phase 11 country
- A Study to Learn About Ritlecitinib for the Potential Treatment of Chronic Spontaneous Urticaria in Adults.RecruitingNCT07219615Phase 210 countries
- Comparing Standard-Dose and High-Dose Cetirizine for Acute UrticariaRecruitingNCT07236372Not applicable1 country
- Use of a Digital Psychotherapeutic App to Reduce Symptom Burden in Dermatology PatientsRecruitingNCT06702293Not applicable1 country
- Angioedema Biomarker Research StudyRecruitingNCT062106981 country
- A Randomised Controlled Trial of ePROM-Guided Flexible Scheduling in DermatologyNot yet recruitingNCT07481019Not applicable
- Efficacy of Auricular Acupressure Combined With Antihistamines in Patients With Wind-Heat Type Urticaria.Not yet recruitingNCT07575464Not applicable1 country
- Allergy and Immunology Natural History StudyRecruitingNCT055844881 country
- Global Managed Access Program Cohort for Remibrutinib in Adult Patients With Chronic Spontaneous UrticariaAvailableNCT05170724
- SKIN Disease Profiling by an Exploratory, pRospective, Biomarker Study in dermatoloGY Practice (SKINERGY)RecruitingNCT070214951 country
- Identification of Subpopulations of Patients With Cholinergic Urticaria Based on Infrared Exposure Test Results.Not yet recruitingNCT06948188Not applicable1 country
- A Clinical Study to Assess the Safety and Effectiveness of Utixira Lotion and Utixira Tablet in Healthy Adult Human Subjects With Dry or Sensitive Skin Prone to Mild to Moderate Pruritus and UrticariaNot yet recruitingNCT06924840Not applicable
- Survey on the Characteristics of Traditional Medicine Syndromes in Urticaria Patients At Le Van Thinh HospitalNot yet recruitingNCT06859736
- Phase III Clinical Study of Cetirizine Hydrochloride Injection in Treatment of Acute UrticariaRecruitingNCT06819774Phase 31 country
- Different Methods of Tranexamic Acid Application in Controlling Peri Operative Bleeding in Gynecomastia SurgeryNot yet recruitingNCT06509256Early Phase 1
- Assessment of Serum Levels of Janus Kinase 1 and 2 in Patients With Cholinergic UrticariaRecruitingNCT06201780Not applicable1 country
- Study on the Influence of Climatic and Environmental Factors on Respiratory Diseases in Sanya, Hainan Province, China.RecruitingNCT053306371 country
- The Association Between Human Microbiome and Vitamin D in Chronic UrticariaRecruitingNCT05497596Not applicable1 country
- A Single-Arm Exploratory Study of NatureU Hista Dissolve on Chronic Urticaria SymptomsCompletedNCT07611032Not applicable1 country
- Phase 3b Study to Assess the Efficacy, Safety, and Tolerability of Remibrutinib in Comparison to Placebo, With Omalizumab as Active Control, in Adult CSU Patients, Followed by an Open-label 52-week Optional Extension.Active, not recruitingNCT06042478Phase 323 countries
- Real-world Evaluation of the Effectiveness of Immunoglobulin-Histamine Complex, IHC (Histoglob) in Chronic UrticariaCompletedNCT076804131 country
- Cause of Unexplained AnaphylaxisCompletedNCT007197191 country
- Efficacy and Safety of HA35 Gel for Ultra-Rapid Skin Pruritus ReliefCompletedNCT07580911Not applicable1 country
- Dose Escalation Trial Of Safety, Pharmacokinetic/Pharmacodynamic And Preliminary Clinical Activity of Briquilimab In Adult Patients With Chronic Spontaneous Urticaria (CSU)CompletedNCT06162728Phase 1/22 countries
- A Phase 1 Study of Cizutamig in IgE Mediated DiseasesWithdrawnNCT07408869Phase 11 country
- Phase 2b Study of EVO756 in Adults With Moderate to Severe Chronic Spontaneous Urticaria (CSU)CompletedNCT06873516Phase 23 countries
- Safety and Efficacy of Intranasal Epinephrine After Administration of ARS -1 in Subjects With Frequent Urticaria FlaresCompletedNCT05496465Phase 21 country
- Pathogenesis of Physical Induced Urticarial SyndromesCompletedNCT008879391 country
- Study Evaluating the Efficacy and Safety of Povorcitinib in Adults With Chronic Spontaneous UrticariaCompletedNCT05936567Phase 23 countries
- Evaluating an Artificial Intelligence Tool to Help Primary Care Doctors Diagnose Skin Conditions.CompletedNCT074289411 country
- Using Artificial Intelligence to Help Doctors Identify Different Skin Conditions and Improve Patient CareCompletedNCT074289541 country
- Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effects of EP262 in Subjects With Chronic Spontaneous UrticariaTerminatedNCT06077773Phase 26 countries
- A Dose Escalation Trial of Safety, Pharmacokinetic/Pharmacodynamic and Preliminary Clinical Activity of Briquilimab in Adult Patients With Chronic Inducible Urticaria (CIndU) Who Remain Symptomatic Despite Treatment With H1- AntihistaminesTerminatedNCT06353971Phase 1/21 country
- COrticosteroids in acUte uRticAria in emerGency dEpartmentCompletedNCT03545464Phase 31 country
- To Compare and Evaluate the Oral Bioavailability of Bilastine 20 mg Orally Dispersible Tablet With That of Bilaxten (Bilastine) 20 mg Orally Dispersible Tablet in Healthy, Adult, Human Subjects Under Fasting ConditionsCompletedNCT07042828Phase 11 country
- GI Symptoms in Infants Fed Goat Milk-based Infant FormulaCompletedNCT067554241 country
- A Study to Investigate the Use of Benralizumab in Patients With Bullous Pemphigoid.TerminatedNCT04612790Phase 311 countries
- A Study to Assess Subcutaneous Lirentelimab (AK002) in Chronic Spontaneous UrticariaTerminatedNCT05528861Phase 23 countries
- A Comparative Double-blind, Double-dummy Study of Desloratadine (DL) 5 mg Once Daily, Cetirizine 10 mg Once Daily, and Placebo Once Daily in Patients With Chronic Idiopathic Urticaria (Study P03736)TerminatedNCT00751166Phase 4
- A Comparison of Aerius Continuous Treatment Versus Aerius PRN for Chronic Idiopathic Urticaria (Study P03147)CompletedNCT00783354Phase 4
- A Comparative Double-Blind, Double- Dummy Study of Desloratadine (DL) 5 MG Once Daily, Cetirizine 10 MG Once Daily, and Placebo Once Daily in Patients With Chronic Idiopathic Urticaria (Study P03735)CompletedNCT00751218Phase 4
- Study of Efficacy and Safety of Ligelizumab in Adolescents and Adults With Chronic Inducible Urticaria Who Remain Symptomatic Despite Treatment With H1- AntihistaminesTerminatedNCT05024058Phase 39 countries
- An Efficacy and Safety Study of Desloratadine (MK-4117) in Japanese Participants With Chronic Urticaria (MK-4117-201)CompletedNCT01916967Phase 3
- Trial to Assess the Efficacy and Safety of LEO 152020 in Adult Patients With Cholinergic UrticariaCompletedNCT04853992Phase 21 country
- Mepolizumab in Episodic Angioedema With EosinophiliaTerminatedNCT04128371Phase 21 country
- A Study to Investigate the Use of Benralizumab in Patients With Chronic Spontaneous Urticaria Who Are Symptomatic Despite the Use of Antihistamines (ARROYO)TerminatedNCT04612725Phase 27 countries
- Safety, Tolerability and Pharmacokinetics Trial of JDP-205 Injection 10 mgCompletedNCT02024152Phase 11 country
- A Pilot Single Dose Crossover Pharmacokinetics Study Of JDP-205 Injection, 10 mg, In Healthy Male And Female VolunteersCompletedNCT02045524Phase 11 country
- Pilot Phase III Clinical Trial of JDP-205 IV Injection for Treatment of Acute UrticariaCompletedNCT02023164Phase 32 countries